Sue Adamson is the Subject of a New Interview
The clinical director of the Kamloops, British Columbia-based Sage Health Center sat down to discuss her life, her career, and...
News
INmune Bio, Inc. Announces Multiple Oral and Poster Presentations at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Annual Meeting
Boca Raton, Florida, Oct. 27, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company...
1Life Healthcare (One Medical) Executives to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that Amir Dan...
Healthy Alliance IPA and Unite Us Partner to Launch New York-Statewide Social Care Network
The partners combine industry-leading technology and on-the-ground community expertise to improve access to services addressing social determinants of healthNEW YORK,...
World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor
Focus on expanding the delivery of controlled-substances in a microneedle patch.Evaluating potential uses of a microneedle patch for infectious diseases.Strengthening...
Better Choice Company to Host Third Quarter 2021 Earnings Call on November 10th at 8:30 a.m. ET
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice”), a pet health and wellness...
PDS Biotech Chief Medical Officer, Lauren V. Wood, to Present at the 2021 International Head and Neck Cancer Conference
FLORHAM PARK, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Health Catalyst to Announce Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021
SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of...
Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites
ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study Completion of the Study Expected...
Sarepta Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Developments on November 3, 2021
CAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
Truepill Raises $142 Million Series D to Continue Transforming Consumer Healthcare
Funding round brings total investment to $256 million and valuation to $1.6 billionSAN MATEO, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE)...
Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that...
Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease
Agreement Provides for Option to License Alzheimer’s TherapeuticEnglewood Cliffs, NJ, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB:...
TRACON to Report Third Quarter 2021 Financial Results and Company Highlights on November 3, 2021
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development...
Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma
WILMETTE, Ill., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
Histogen to Report Third Quarter 2021 Financial Results on November 10, 2021
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential...
Science 37® and CMIC Announce Partnership to Advance Decentralized Clinical Trials in Japan/APAC and Speed Drug Development
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical...
Aveanna Announces Third Quarter 2021 Earnings Release Date and Conference Call
ATLANTA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) today announced that the company will release...
Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting™ 2021, Hosted by the AASLD
New data regarding the mechanism of action of belapectin to inhibit galectin-3Unique pharmacokinetic profile of belapectin in patients with hepatic...
Access Vascular Inc. and Eloquest Healthcare Partner to Improve Vascular Access Outcomes
The partnership combines Eloquest’s existing clinically oriented product offering and commercial resources with AVI’s transformational device technologyBEDFORD, Mass., Oct. 27,...
